Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 02, 2021 Filed Nov 4, 2021 19:36 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
SaleCommon Stock | 928 | $147.51 | $136,891.14 |
DisclosureSEC source: 0001127602-21-028376 · form4.xml · nonDerivative · entry 7 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,247 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.94 to $147.88. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 19:36 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
Exercise / conversionCommon Stock | 1,800 | $78.76 | $141,768.00 |
DisclosureSEC source: 0001127602-21-028376 · form4.xml · nonDerivative · entry 6 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,175 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 19:36 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
SaleCommon Stock | 3,278 | $147.57 | $483,734.46 |
DisclosureSEC source: 0001127602-21-028376 · form4.xml · nonDerivative · entry 5 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,375 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.36 to $147.96. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 19:36 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
SaleCommon Stock | 1,822 | $147.06 | $267,937.85 |
DisclosureSEC source: 0001127602-21-028376 · form4.xml · nonDerivative · entry 4 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,653 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.34 to $147.31. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 19:36 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
Exercise / conversionCommon Stock | 5,100 | $59.96 | $305,796.00 |
DisclosureSEC source: 0001127602-21-028376 · form4.xml · nonDerivative · entry 3 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,475 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 19:36 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
SaleCommon Stock | 862 | $146.67 | $126,427.82 |
DisclosureSEC source: 0001127602-21-028376 · form4.xml · nonDerivative · entry 2 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,375 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.24 to $147.01. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 19:36 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
Exercise / conversionCommon Stock | 862 | $41.93 | $36,143.66 |
DisclosureSEC source: 0001127602-21-028376 · form4.xml · nonDerivative · entry 1 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,237 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 20:59 UTC |
Beyer PatPresident Int'l & Global Ortho
|
Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 50,700 | $0.00 Strike: $51.30 | $0.00 |
DisclosureSEC source: 0001127602-21-028140 · form4.xml · derivative · entry 9 Beyer Pat · CIK 0001627985 · President Int'l & Global Ortho 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,700 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Plan and generally vest in equal amounts (20%) over a five year period. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 20:59 UTC |
Beyer PatPresident Int'l & Global Ortho
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 55,300 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-21-028140 · form4.xml · derivative · entry 8 Beyer Pat · CIK 0001627985 · President Int'l & Global Ortho 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 55,300 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 20:59 UTC |
Beyer PatPresident Int'l & Global Ortho
|
Tax withholdingCommon Stock | 33,253 | $146.28 | $4,864,248.84 |
DisclosureSEC source: 0001127602-21-028140 · form4.xml · nonDerivative · entry 7 Beyer Pat · CIK 0001627985 · President Int'l & Global Ortho 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,254 Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 20:59 UTC |
Beyer PatPresident Int'l & Global Ortho
|
Exercise / conversionCommon Stock | 50,700 | $51.30 | $2,600,910.00 |
DisclosureSEC source: 0001127602-21-028140 · form4.xml · nonDerivative · entry 6 Beyer Pat · CIK 0001627985 · President Int'l & Global Ortho 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,507 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 20:59 UTC |
Beyer PatPresident Int'l & Global Ortho
|
SaleCommon Stock | 5,589 | $146.14 | $816,748.52 |
DisclosureSEC source: 0001127602-21-028140 · form4.xml · nonDerivative · entry 5 Beyer Pat · CIK 0001627985 · President Int'l & Global Ortho 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,807 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $145.93 to $146.53. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 20:59 UTC |
Beyer PatPresident Int'l & Global Ortho
|
SaleCommon Stock | 16,904 | $145.31 | $2,456,269.53 |
DisclosureSEC source: 0001127602-21-028140 · form4.xml · nonDerivative · entry 4 Beyer Pat · CIK 0001627985 · President Int'l & Global Ortho 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,396 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.92 to $145.92. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 20:59 UTC |
Beyer PatPresident Int'l & Global Ortho
|
SaleCommon Stock | 2,789 | $144.50 | $403,002.13 |
DisclosureSEC source: 0001127602-21-028140 · form4.xml · nonDerivative · entry 3 Beyer Pat · CIK 0001627985 · President Int'l & Global Ortho 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,300 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.90 to $144.88. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 20:59 UTC |
Beyer PatPresident Int'l & Global Ortho
|
Tax withholdingCommon Stock | 30,018 | $144.62 | $4,341,203.16 |
DisclosureSEC source: 0001127602-21-028140 · form4.xml · nonDerivative · entry 2 Beyer Pat · CIK 0001627985 · President Int'l & Global Ortho 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,089 Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 20:59 UTC |
Beyer PatPresident Int'l & Global Ortho
|
Exercise / conversionCommon Stock | 55,300 | $39.87 | $2,204,811.00 |
DisclosureSEC source: 0001127602-21-028140 · form4.xml · nonDerivative · entry 1 Beyer Pat · CIK 0001627985 · President Int'l & Global Ortho 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,107 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 01:25 UTC |
Garner Todd WExecutive Vice President & CFO
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 8,400 | $0.00 Strike: $50.61 | $0.00 |
DisclosureSEC source: 0001127602-21-026746 · form4.xml · derivative · entry 11 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,600 Underlying: Common Stock · 8,400 shares Expires 2028-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: Each Stock Option represents a contingent right to receive one share of common stock, par value $0.001, per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (20%) over a five year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 01:25 UTC |
Garner Todd WExecutive Vice President & CFO
|
SaleCommon Stock | 500 | $133.45 | $66,723.00 |
DisclosureSEC source: 0001127602-21-026746 · form4.xml · nonDerivative · entry 10 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.13 to $133.99. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 01:25 UTC |
Garner Todd WExecutive Vice President & CFO
|
SaleCommon Stock | 900 | $132.65 | $119,385.90 |
DisclosureSEC source: 0001127602-21-026746 · form4.xml · nonDerivative · entry 9 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.11 to $133.10. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 01:25 UTC |
Garner Todd WExecutive Vice President & CFO
|
SaleCommon Stock | 800 | $131.49 | $105,193.60 |
DisclosureSEC source: 0001127602-21-026746 · form4.xml · nonDerivative · entry 8 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,400 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.92 to $131.91. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 01:25 UTC |
Garner Todd WExecutive Vice President & CFO
|
SaleCommon Stock | 3,083 | $130.05 | $400,937.98 |
DisclosureSEC source: 0001127602-21-026746 · form4.xml · nonDerivative · entry 7 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,200 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.72 to $130.60. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 01:25 UTC |
Garner Todd WExecutive Vice President & CFO
|
SaleCommon Stock | 3,117 | $129.38 | $403,271.23 |
DisclosureSEC source: 0001127602-21-026746 · form4.xml · nonDerivative · entry 6 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,283 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.72 to $129.69. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 01:25 UTC |
Garner Todd WExecutive Vice President & CFO
|
Exercise / conversionCommon Stock | 8,400 | $50.61 | $425,124.00 |
DisclosureSEC source: 0001127602-21-026746 · form4.xml · nonDerivative · entry 5 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: All of the exercises and sales submitted on this form were subject to a written 10b5-1 plan. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 01:25 UTC |
Garner Todd WExecutive Vice President & CFO
|
SaleCommon Stock | 32 | $132.99 | $4,255.52 |
DisclosureSEC source: 0001127602-21-026746 · form4.xml · nonDerivative · entry 4 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.79 to $133.15. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 01:25 UTC |
Garner Todd WExecutive Vice President & CFO
|
SaleCommon Stock | 20 | $131.63 | $2,632.50 |
DisclosureSEC source: 0001127602-21-026746 · form4.xml · nonDerivative · entry 3 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.34 to $131.91. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 01:25 UTC |
Garner Todd WExecutive Vice President & CFO
|
SaleCommon Stock | 81 | $130.13 | $10,540.45 |
DisclosureSEC source: 0001127602-21-026746 · form4.xml · nonDerivative · entry 2 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.75 to $130.72. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 01:25 UTC |
Garner Todd WExecutive Vice President & CFO
|
SaleCommon Stock | 58 | $129.33 | $7,500.97 |
DisclosureSEC source: 0001127602-21-026746 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.75 to $129.73. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 15:26 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
GrantCommon Stock | 16 | $124.29 | $1,988.64 |
DisclosureSEC source: 0001127602-21-026386 · form4.xml · nonDerivative · entry 1 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,153 Read SEC document |
| September 17, 2021 Filed Sep 17, 2021 20:42 UTC |
Hartman Curt RDirector · President, CEO and Chair
|
GiftCommon Stock | 89,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-025509 · form4.xml · nonDerivative · entry 7 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 89,000 F2 · kind: This transaction involved a gift of securities by the reporting person to a trust in which the reporting person's spouse is the trustee. The reporting person disclaims beneficial ownership of the shares held by the trust, and this report should not be deemed an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| September 17, 2021 Filed Sep 17, 2021 20:42 UTC |
Hartman Curt RDirector · President, CEO and Chair
|
GiftCommon Stock | 89,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-025509 · form4.xml · nonDerivative · entry 6 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,949 F2 · kind: This transaction involved a gift of securities by the reporting person to a trust in which the reporting person's spouse is the trustee. The reporting person disclaims beneficial ownership of the shares held by the trust, and this report should not be deemed an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:42 UTC |
Hartman Curt RDirector · President, CEO and Chair
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 47,500 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-21-025509 · form4.xml · derivative · entry 9 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,650 Underlying: Common Stock · 47,500 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:42 UTC |
Hartman Curt RDirector · President, CEO and Chair
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 34,000 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-21-025509 · form4.xml · derivative · entry 8 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 34,000 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:42 UTC |
Hartman Curt RDirector · President, CEO and Chair
|
Tax withholdingCommon Stock | 28,182 | $127.28 | $3,587,004.96 |
DisclosureSEC source: 0001127602-21-025509 · form4.xml · nonDerivative · entry 5 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,949 Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:42 UTC |
Hartman Curt RDirector · President, CEO and Chair
|
Exercise / conversionCommon Stock | 47,500 | $41.93 | $1,991,675.00 |
DisclosureSEC source: 0001127602-21-025509 · form4.xml · nonDerivative · entry 4 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,131 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:42 UTC |
Hartman Curt RDirector · President, CEO and Chair
|
Tax withholdingCommon Stock | 19,349 | $127.24 | $2,462,015.13 |
DisclosureSEC source: 0001127602-21-025509 · form4.xml · nonDerivative · entry 3 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,631 Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:42 UTC |
Hartman Curt RDirector · President, CEO and Chair
|
Exercise / conversionCommon Stock | 34,000 | $39.87 | $1,355,580.00 |
DisclosureSEC source: 0001127602-21-025509 · form4.xml · nonDerivative · entry 2 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,980 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:42 UTC |
Hartman Curt RDirector · President, CEO and Chair
|
SaleCommon Stock | 2,500 | $127.39 | $318,467.50 |
DisclosureSEC source: 0001127602-21-025509 · form4.xml · nonDerivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,980 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.31 to $127.42. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:39 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 11,000 | $0.00 Strike: $59.96 | $0.00 |
DisclosureSEC source: 0001127602-21-025507 · form4.xml · derivative · entry 5 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:39 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-025507 · form4.xml · nonDerivative · entry 4 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,137 Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:39 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Tax withholdingCommon Stock | 8,327 | $127.56 | $1,062,192.12 |
DisclosureSEC source: 0001127602-21-025507 · form4.xml · nonDerivative · entry 3 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,137 Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:39 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Exercise / conversionCommon Stock | 11,000 | $59.96 | $659,560.00 |
DisclosureSEC source: 0001127602-21-025507 · form4.xml · nonDerivative · entry 2 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,464 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:39 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
SaleCommon Stock | 3,357 | $127.26 | $427,202.08 |
DisclosureSEC source: 0001127602-21-025507 · form4.xml · nonDerivative · entry 1 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,464 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.20 to $127.265. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:33 UTC |
Garner Todd WExecutive Vice President & CFO
|
SaleCommon Stock | 1,131 | $124.92 | $141,284.52 |
DisclosureSEC source: 0001127602-21-025499 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 15, 2021. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 20:37 UTC |
TRYNISKI MARK EDirector
|
GiftCommon Stock | 36,114 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-025410 · form4.xml · nonDerivative · entry 2 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 36,114 F1 · kind: This transaction involved a gift of securities by the reporting person to a trust in which the reporting person's spouse is the trustee. The reporting person disclaims beneficial ownership of the shares held by the trust, and this report should not be deemed an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 20:37 UTC |
TRYNISKI MARK EDirector
|
GiftCommon Stock | 36,114 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-025410 · form4.xml · nonDerivative · entry 1 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,296 F1 · kind: This transaction involved a gift of securities by the reporting person to a trust in which the reporting person's spouse is the trustee. The reporting person disclaims beneficial ownership of the shares held by the trust, and this report should not be deemed an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 21:13 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 200 | $0.00 Strike: $97.69 | $0.00 |
DisclosureSEC source: 0001127602-21-024594 · form4.xml · derivative · entry 12 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,300 Underlying: Common Stock · 200 shares Expires 2030-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 21:13 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 100 | $0.00 Strike: $78.76 | $0.00 |
DisclosureSEC source: 0001127602-21-024594 · form4.xml · derivative · entry 11 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 100 shares Expires 2029-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 21:13 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 300 | $0.00 Strike: $59.96 | $0.00 |
DisclosureSEC source: 0001127602-21-024594 · form4.xml · derivative · entry 10 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,900 Underlying: Common Stock · 300 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 21:13 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 3,640 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-21-024594 · form4.xml · derivative · entry 9 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,862 Underlying: Common Stock · 3,640 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 21:13 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
SaleCommon Stock | 200 | $134.75 | $26,950.00 |
DisclosureSEC source: 0001127602-21-024594 · form4.xml · nonDerivative · entry 8 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,375 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.